Monday 30 June 2025

Science Daily

  1. Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer’s and other dementias. It turns out neurons don’t just store sugar for fuel—they reroute it to power antioxidant defenses, but only if an enzyme called GlyP is active. When this sugar-clearing system is blocked, toxic tau protein builds up and accelerates brain degeneration.
  2. An AI system called iSeg is reshaping radiation oncology by automatically outlining lung tumors in 3D as they shift with each breath. Trained on scans from nine hospitals, the tool matched expert clinicians, flagged cancer zones some missed, and could speed up treatment planning while reducing deadly oversights.
  3. Leprosy’s tale stretches from 5,000-year-old skeletons in Eurasia to a startling 4,000-year-old case in Chile, revealing that the rare strain Mycobacterium lepromatosis haunted the Americas millennia before Europeans arrived. Armed with cutting-edge ancient-DNA sleuthing, scientists have pieced together remarkably well-preserved genomes that challenge the idea of leprosy as purely a colonial import and hint that the disease may have homegrown American roots awaiting confirmation by future finds.
  4. In a stellar nursery 460 light-years away, astronomers sharpened old ALMA data and spotted crisp rings and spirals swirling around 27 infant stars—evidence that planets start taking shape just a few hundred thousand years after their suns ignite, far earlier than anyone expected.
  5. Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during inflammation. This breakthrough could offer a powerful new way to fight heart disease, diabetes, cancer, and more. By "turning off" this enzyme, the team restored cholesterol absorption in macrophages, potentially stopping disease at the source. Even more promising, they found a second enzyme, NOS, that makes things worse—raising hopes that targeting both could pave the way for transformative treatments for millions suffering from inflammation-driven conditions.

Membership